Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.

Medicine (Baltimore) · 2018 · PMC5943891 · PMID 29480828

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Liu et al [ 13 ] compared event-free survival (EFS) and OS between BRCA1 and BRCA2 patients, and found no difference in the 2 measures between the 2 genotypes, though there was a nonsignificant trend towards improved OS in BRCA2 patients with advanced-stage disease.

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.